• Practical Guide: Hoechst 33342/PI Double Staining Kit (K2237

  2026-06-13

  The Hoechst 33342/PI Double Staining Kit addresses the need for rapid, dual-fluorescent identification of viable, apoptotic, and necrotic cells by leveraging nuclear and membrane integrity markers. It is best suited for basic research workflows relying on microscopy or fluorescence-based analysis and should not be used in diagnostic or clinical settings.

• Neuroligin 1 Loss in D2-MSNs Drives Repetitive Behaviors via

  2026-06-12

  This study identifies the absence of Neuroligin 1 in striatal D2-MSNs as a key driver of autistic-like repetitive behaviors through neural hyperactivation and PKC overactivity. The findings clarify cell-type-specific mechanisms underlying restricted and repetitive behaviors (RRBs) in autism models, providing new molecular targets for intervention.

• Batimastat (BB-94) in Applied MMP Inhibition Workflows

  2026-06-12

  Batimastat (BB-94) enables precise, broad-spectrum MMP inhibition, uniquely supporting studies of BDNF proteolytic processing and tumor microenvironment remodeling. This guide translates bench breakthroughs into actionable protocols, troubleshooting, and advanced use-cases for cancer and neuromuscular research.

• FH1 (B3700): Transforming iPS Hepatocyte Maturation for Adva

  2026-06-11

  Explore how FH1 small molecule (Catalog No. B3700) uniquely drives functional maturity in iPS-derived hepatocytes. This in-depth article analyzes FH1's mechanisms, assay impact, and its synergy with next-generation gene regulation, offering researchers a distinct, evidence-based perspective.

• Tolazoline: α2-Adrenergic Antagonist Profiles and Research U

  2026-06-11

  Tolazoline is a validated α2-adrenergic receptor antagonist used in in vitro airway smooth muscle and islet function research. Its dual action on α2-adrenergic receptors and ATP-sensitive K+ channels supports precise modulation of insulin secretion and neurotransmitter release. APExBIO provides high-purity Tolazoline (SKU A8991) for reliable experimental protocols.

• FAISL lncRNA Shields FAK from Calpain 2, Driving TNBC Progre

  2026-06-10

  The reference study identifies the long noncoding RNA FAISL as a novel regulator that stabilizes FAK protein by inhibiting Calpain 2-mediated proteolysis in triple negative breast cancer (TNBC). This mechanistic insight reveals a new axis for tumor progression and suggests lncRNA FAISL as a promising therapeutic target in aggressive breast cancers.

• L-Phenylephrine: Decoding α1A Receptor Signaling and Hyperte

  2026-06-10

  Explore the molecular pharmacology of L-Phenylephrine as a selective adrenergic α1A receptor agonist. This in-depth article uniquely bridges receptor-mediated vasoconstriction with sex-specific hypertension mechanisms, providing advanced perspectives for cardiovascular research.

• DAMGO: Precision µ-Opioid Receptor Agonist in Pain Pathway R

  2026-06-09

  DAMGO stands apart as a gold-standard selective µ-opioid receptor agonist, empowering researchers to dissect opioid signaling and analgesic mechanisms with exceptional specificity. Its robust, reproducible performance in both in vitro and in vivo models drives advances in chronic pain and opioid receptor pharmacology studies.

• Cyclosporin A (B1922): Technical Guide for Immunosuppression

  2026-06-09

  Cyclosporin A is a potent immunosuppressant and cyclophilin inhibitor widely used for investigating T-cell signaling, apoptosis, and mitochondrial pathways in cell and animal models. It offers precise suppression of immune responses and is particularly suited for autoimmune disorder research, retinal ischemic injury models, and viral entry inhibition workflows. It should not be used where aqueous solubility or extended solution stability is required.

• AZD8055: Protocol Guidance for mTORC1/mTORC2 Inhibition

  2026-06-08

  AZD8055 is a potent, selective mTOR inhibitor for dissecting mTORC1 and mTORC2 signaling in preclinical cancer and metabolic models. It is unsuitable for studies focused on clinical efficacy endpoints but is well-suited for mechanistic research requiring precise mTOR inhibition.

• Tolazoline: Applied α2-Adrenergic Antagonism in Airway and I

  2026-06-08

  Tolazoline stands out as a research-grade α2-adrenergic receptor antagonist, uniquely bridging in vitro airway smooth muscle studies and islet function assays. This article delivers actionable protocols, troubleshooting insights, and comparative guidance for leveraging Tolazoline’s dual pharmacology in translational workflows.

• PAD4-IN-2 TFA: Decoding Tumor-Specific PAD4 Inhibition Mecha

  2026-06-07

  Explore how PAD4-IN-2 TFA achieves tumor-specific PAD4 inhibition through meta-phenylboronic acid modification, offering unique insights into immune modulation and translational cancer research. This article delivers a deeper mechanistic analysis for researchers seeking advanced understanding.

• Machine Learning-Driven Discovery of Senolytics: New Paradig

  2026-06-06

  The referenced study pioneers a machine learning approach for senolytic drug discovery, dramatically reducing screening costs and expanding the repertoire of compounds targeting cellular senescence. This innovation provides a robust framework for identifying agents with therapeutic potential in age-related and cancer pathologies.

• Optimizing Apoptosis Detection with One-step TUNEL Cy5 Kit

  2026-06-05

  This article addresses real-world laboratory challenges in apoptosis quantification and demonstrates how the One-step TUNEL Cy5 Apoptosis Detection Kit (SKU K1135) provides reliable, sensitive, and reproducible results. By leveraging scenario-driven Q&A, we illustrate evidence-based best practices for cell death analysis in diverse experimental contexts. Researchers seeking robust performance and streamlined workflows will find actionable guidance grounded in current literature and validated protocols.

• CCK-8 Cell Proliferation Assay: Precision in Cancer Research

  2026-06-05

  Unlock the power of the Cell Counting Kit-8 (CCK-8) for sensitive, high-throughput cell viability and cytotoxicity measurement in disease modeling and drug discovery. Discover workflow optimizations, troubleshooting tips, and the latest insights from urinary bladder cancer research that position CCK-8 as an essential tool for translational studies.

455 records 15/31 page Previous Next First page 上5页 1112131415 下5页 Last page